Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business

Jan 09, 2019

|

SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, according to CEO and Cofounder Chad Robins.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Featured White Papers

High-Throughput Detection of SARS-CoV-2 Using COVIDSeq NGS: A GenomeWeb eCase Study Transcript

NGS-Based Target Capture for SARS-CoV-2 Detection and Characterization

Feb

22

Featured Webinar

Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.

Feb

23

Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.

Feb

24

Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.

Feb

26

Featured Webinar

Responding to Emerging SARS-CoV-2 Variants: The Impact on Existing Diagnostic Testing and the Clinical Utility of Differentiation Assays

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.

Menu

Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business

To read the full story....

Breaking News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

In Brief This Week: Myriad Genetics, Precipio, LumiraDx, Guardant Health, and More

President Biden Announces Plan to Expand SARS-CoV-2 Testing, Increase Capacity

Genetic Technologies to Raise $6.6M in Direct Offering

Numares Collaborating With Bruker on NMR-based Diagnostics

CareDx Prices $175M Common Stock Offering

Featured White Papers

Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Responding to Emerging SARS-CoV-2 Variants: The Impact on Existing Diagnostic Testing and the Clinical Utility of Differentiation Assays

What's Popular?

Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test

Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection

Sponsorships